As of January 23, 2025, Oncodesign Precision Medicine Opm SA (ALOPM.PA) has a market cap of $11.729 million USD. According to our data, Oncodesign Precision Medicine Opm SA is ranked No.8810 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $11.73 M |
-13.17%
|
Dec 31, 2024 | $13.51 M |
-60.55%
|
Dec 29, 2023 | $34.24 M |
6.47%
|
Dec 30, 2022 | $32.16 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
USA
|
Relay Therapeutics
RLAY
|
$0.82 B |
0.000 M
|
USA
|
Zymeworks
ZYME
|
$1.01 B |
-0.000 M
|
Canada
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
Revolution Medicines
RVMD
|
$7.56 B |
0.000 M
|
USA
|
G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
USA
|
Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
Market Cap | = | ALOPM.PA Stock Price | * | ALOPM.PA Shares Outstanding |
= | $0.65 | * | 18.17 M | |
= | $11.73 M |